Cargando…
Direct costs of chronic obstructive pulmonary disease among managed care patients
PURPOSE: To estimate patient- and episode-level direct costs of chronic obstructive pulmonary disease (COPD) among commercially insured patients in the US. METHODS: In this retrospective claims-based analysis, commercial enrollees with evidence of COPD were grouped into five mutually exclusive cohor...
Autores principales: | Dalal, Anand A, Christensen, Laura, Liu, Fang, Riedel, Aylin A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2962300/ https://www.ncbi.nlm.nih.gov/pubmed/21037958 http://dx.doi.org/10.2147/COPD.S13771 |
Ejemplares similares
-
Cost trends among commercially insured and Medicare Advantage-insured patients with chronic obstructive pulmonary disease: 2006 through 2009
por: Dalal, Anand A, et al.
Publicado: (2011) -
The direct and indirect costs of managing chronic obstructive pulmonary disease in Greece
por: Souliotis, Kyriakos, et al.
Publicado: (2017) -
Indirect costs in chronic obstructive pulmonary disease: A review of the economic burden on employers and individuals in the United States
por: Patel, Jeetvan G, et al.
Publicado: (2014) -
Direct and Indirect Costs of Chronic Obstructive Pulmonary Disease in Korea
por: Kim, Changhwan, et al.
Publicado: (2019) -
Impact of Integrated Care Model (ICM) on Direct Medical Costs in Management of Advanced Chronic Obstructive Pulmonary Disease (COPD)
por: Bandurska, Ewa, et al.
Publicado: (2017)